semaglutide news oct 26 2025 When Joshua Hunt (@viajoshhunt) started Ozempic in April 2025, the weekly dose of the GLP-1 agonist transformed him. This past March, when he decided to stop, his cravings returned — for semaglutide news october 26 2025

They should remind patients to seek care promptly if they experience severe stomach pain, a neck lump, persistent hoarseness, or difficulty swallowing

KEY TAKEAWAYS BY PRODUCT Ozempic dominated the GLP-1 agonists market owing to its high adoption for the management of type 2 diabetes, wide geographic availability, and a strong brand recognition

Effects of iron intake on neurobehavioural outcomes in African children: a systematic review and meta-analysis of randomised controlled trials

In addition to its critical role in energy metabolism, it acts as an extracellular signaling molecule that binds to and activates its specific G-protein-coupled receptor (GPR91), a receptor in HSCs whose role in hepatic fibrosis remains unclear

In terms of immune modulation, GLP-1RAs demonstrate a bidirectional mechanism: they can enhance anti-tumor immune responses while modulating systemic inflammatory processes